Lin Wang

Dr. Lin Wang


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 October 2024 in Journal of Cardiac Failure
Verified
Journal Article
Closed access
LWLin Wang
Lin Wang
JWJonathan Weber
Jonathan Weber
JCJason Craft
Jason Craft
MPMichael Passick
Michael Passick
OKOmar Khalique
Omar Khalique
JCJ. Jane Cao
J. Jane Cao

30 August 2020 in Cureus
Verified
Journal Article
Open access
PDF file
HZHaoyi Zheng
Haoyi Zheng
KSKathleen Stergiopoulos
Kathleen Stergiopoulos
LWLin Wang
Lin Wang
LCLu Chen
Lu Chen
JCJane Cao
Jane Cao
This case series describes clinical course of three COVID-19 patients who presented with major thromboembolic events. Patient 1 is a 57-year-old male with asymptomatic COVID-19 who presented with a large left ventricular thrombus. His hospital course was complicated with a stroke. Patient 2 is a 71-year-old male with mild COVID-19 who presented with an acute stroke. Patient 3 is a 47-year-old male with severe COVID-19 who presented with a large pulmonary embolism. He died of a recurrent massive pulmonary embolism. This case series demonstrates that thromboembolic event can be the presenting feature of COVID-19 and can occur in the patients with asymptomatic or mild COVID-19. Diffuse endothelial injury and hypercoagulability play a pivotal role in recurrent thromboembolic events despite the anticoagulation. Therapeutic anticoagulation may be considered for severe COVID-19 patients and patients with important comorbidities or pre-existing endothelial dysfunction.

1 November 2019 in The American Journal of Cardiology
Verified
Journal Article
Closed access
WCWei Chen
Wei Chen
ABAndrew Berke
Andrew Berke
WCWilliam Chung
William Chung
EKElena Koss
Elena Koss
AGAarsha Gopal
Aarsha Gopal
LWLin Wang
Lin Wang

13 June 2024 in Journal of the Society for Cardiovascular Angiography & Interventions
Verified
Journal Article
Open access
LWLin Wang
Lin Wang
GPGeorge Petrossian
George Petrossian
NRNewell Robinson
Newell Robinson
WCWilliam Chung
William Chung
JKJaffar Khan
Jaffar Khan
OKOmar Khalique
Omar Khalique

2 November 2026 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
MMMałgorzata Maciorowska
Małgorzata Maciorowska
APAna Pastorino
Ana Pastorino
LWLin Wang
Lin Wang
SBSylvia Biso
Sylvia Biso
BTBillal Tokhi
Billal Tokhi
OKOmar Khalique
Omar Khalique
Aortic regurgitation (AR) is a complex and often misdiagnosed valvular heart disease. It is often asymptomatic for years, making early detection critical. Once symptoms develop, left ventricular dysfunction may already be irreversible. Timely and accurate grading of AR severity can guide clinical decision-making and improve survival rates. Delayed diagnosis increases the risk of heart failure, arrhythmias, and sudden cardiac death. Transthoracic echocardiography (TTE) is the first-line imaging modality, providing assessment of valve morphology, AR severity, left ventricular size and function, and aortic dimensions. When TTE is inconclusive or additional anatomical information is required, complementary imaging modalities provide incremental value. Transesophageal echocardiography often helps to define AR mechanism and is particularly relevant for valve repair assessment and procedural guidance. Cardiovascular magnetic resonance enables accurate quantification of regurgitant volume and fraction, detailed evaluation of ventricular remodeling, and detection of myocardial fibrosis. Cardiac computed tomography offers high-resolution characterization of the aorta and is increasingly important for surgical and transcatheter planning. In selected patients, multimodality imaging also helps evaluate prosthetic valve dysfunction and suspected infective endocarditis. This paper reviews the currently used imaging modalities and their clinical applicability, and proposes an integrated multimodality imaging approach to guide patient management in chronic AR.